Compare BBIO & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBIO | EQX |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 13.5B |
| IPO Year | 2019 | 2018 |
| Metric | BBIO | EQX |
|---|---|---|
| Price | $68.11 | $10.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 23 | 11 |
| Target Price | ★ $107.81 | $15.84 |
| AVG Volume (30 Days) | 2.4M | ★ 9.5M |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $107.07 | $116.94 |
| Revenue Next Year | $60.44 | $27.66 |
| P/E Ratio | ★ N/A | $137.41 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $60.23 | $8.49 |
| 52 Week High | $93.42 | $18.96 |
| Indicator | BBIO | EQX |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 35.64 |
| Support Level | $67.57 | $9.34 |
| Resistance Level | $69.47 | $10.49 |
| Average True Range (ATR) | 1.89 | 0.41 |
| MACD | 0.66 | -0.08 |
| Stochastic Oscillator | 79.57 | 11.06 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. The company operates gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the Canada, United States, Mexico, and others. The majority of its revenue is generated from Canada.